BusinessOctober 20, 2022 Zymeworks strikes $1.8-billion licensing deal labelled ‘bad’ for shareholders by hostile suitor Shares of Zymeworks Inc. ZYME-N rose by 15.7 per cent Wednesday after it announced an unusual licensing deal… byTausi Insider Team
